Meet the MassBioDrive Spring 2025 Cohort
Centron Bio
Centron Bio is a cutting-edge biotechnology company pioneering next-generation genetic medicines for Central Nervous System (CNS) diseases. Centron Bio leverages world-class research and deep expertise in RNA-based therapeutics, peptide delivery, precision medicine, and translational neuroscience to develop breakthrough treatments for patients with high unmet medical needs.
-
James Tran, PhD
CEO
-
Jiah Pearson-Leary
Head of Corporate Development
-
Rick Pierce
Chair-elect
Interactome Biotherapeutics
Interactome is advancing its native nano platform, a next-generation, multi-targeted Secretome containing hundreds of biologically active proteins and other factors crucial for cellular regeneration, the modulation of inflammation, cell recovery and turnover. This novel platform could hold significant clinical potential across a range of important underserved conditions in neurology and cardiology.
Paralog Therapeutics
Paralog Therapeutics is a pre-clinical stage precision medicine company focused on the development of anti-cancer therapies. Paralog Therapeutics’ mission is to identify and leverage synthetic vulnerabilities in cancers that carry specific gene alterations.
-
Tiziana Parisi, PhD
CEO, CSO & Co-founder
-
Steen Hansen, PhD, MD
President & Academic Co-founder
State 4 Therapeutics
State 4 Therapeutics is developing oral small molecule therapies that synergize with nutrient-stimulated hormones for the treatment of obesity and metabolic diseases.
-
Dick Kibbey, MD, PhD
Scientific Founder
-
Matt Merrins, PhD
Scientific Founder
-
Ania Jastreboff, MD, PhD
Founder, Clinical Scientific Advisor
-
Robert Williams, PhD
Lead Operator
TMAB Therapeutics
TMAB Therapeutics is developing first-in-class multi-specific antibodies designed to enhance immune activation while inhibiting angiogenesis within the solid tumor microenvironment. By simultaneously targeting CD5L and EGLF6, TMAB Therapeutics aims to overcome adaptive resistance to anti-VEGF and anti-PD1 therapies, offering a novel treatment approach for non-small cell lung cancer, microsatellite-stable colorectal cancer, and high-grade serous epithelial…
-
Tinashe Chandauka, MD, PhD
Co-founder & CEO
-
Josh Sharan, DO
Co-founder & COO
Inside MassBioDrive
Participating in the MassBioDrive program offers biotech and techbio founders a unique opportunity to accelerate their growth and success. By participating in MassBioDrive, founders can leverage these advantages to drive their innovation, overcome barriers, and make significant strides toward bringing life-changing treatments and technologies to patients worldwide.
During each hybrid 8-week program, the MassBioDrive cohorts are supported with:
Access to Expertise
Startups connected with industry experts, seasoned entrepreneurs, and experienced mentors who provide invaluable guidance on business development, clinical strategy, regulatory pathways, and commercialization.
Networking Opportunities
Unparalleled networking with potential partners, investors, and key stakeholders in the biotech ecosystem to unlock collaborations, funding, and strategic alliances.
Resource Access
Receive an equity-free stipend from Bristol Myers Squibb, along with access to and/or resources from MassBioDrive partners, including Evaluate and Google Startup.
Visibility Opportunities
Cohorts receive additional visibility with top-tier funders and strategic partners through pitch events, showcases, and MassBio social channels.
Community Support
Part of a vibrant and supportive community of like-minded innovators, providing a collaborative environment that fosters knowledge sharing, peer learning, and mutual support.
Accelerated Support
With a focus on intensive learning, startups achieve critical business fundamental milestones faster.
Get Involved
MassBioDrive invites industry professionals and students to support life science startups through mentoring, volunteering as analysts, or providing resources like consulting and technology access.
Meet our Partners
Our partners are experts in areas like drug development, business, legal strategy, and fundraising and provide critical resources, funding, and guidance to help startups thrive in the life sciences industry.
Alumni Testimonials
